“Prevention, prevention, prevention” – the rallying call from Sandra Gallina, Director General of DG SANTE at the European Commission, set the scene for the core theme that ran through the 10th Politico Health Care Summit in Brussels, on 18th and 19th November. The scale of the challenge The non-communicable disease (NCD) burden across Europe is […]
The Movember Institute of Men’s Health has just released a new report, “The Real Face of Men’s Health”, examining the state of men’s health in Canada,
In 2023, five conditions – coronary heart disease (CHD), colorectal cancer, lung cancer, chronic obstructive pulmonary disease (COPD), and suicide – were responsible for the greatest number of years of life lost to ill health among Canadian men.
HealthLumen was commissioned to carry out the health economic modelling for this report. Our modelling showed that if all preventable cases of these five conditions had been avoided in men in 2023, Canada could have saved $12.4 billion CAD.
In 2024, the World Health Organization (WHO) reported that noncommunicable diseases (NCDs) account for approximately 75% of all deaths worldwide.
For pharmaceutical and biotech companies working in CVRMs, understanding future disease burden is essential to long-term strategy in order to inform decisions regarding where, when and how to invest resources for maximum impact of return. This is important when developing therapeutic interventions, but also for identifying where those interventions can have the greatest impact, and for making the case to act sooner.
In this context, epidemiological modelling is playing a growing role in evidence generation.
Chronic kidney disease (CKD) is a major global health issue – affecting an estimated 1 in 10 people – yet it is frequently overlooked on health agendas worldwide. In its early stages, CKD is often asymptomatic, and many individuals are unaware that they have CKD until the disease has progressed to later stages, where it becomes harder and more costly to treat – with patients facing the prospect of dialysis or kidney transplant. This makes early CKD detection critical to improving patient outcomes and reducing the growing health and economic burden of CKD worldwide. Recognising this, the World Kidney Day campaign this year is centred around the theme: “Detect early, protect kidney health.”
When you need a future-facing decision engine for big, real world population health questions, we are the people to turn to.
Solutions